10 Analysts Have This To Say About UnitedHealth Group
Portfolio Pulse from Benzinga Insights
UnitedHealth Group (NYSE:UNH) has received mixed reviews from 10 analysts over the past quarter, with 1 bullish, 7 somewhat bullish, 1 indifferent, and 1 somewhat bearish rating. The average 12-month price target is $573.0, down from $579.25, with a high estimate of $610.00 and a low of $480.00. Analysts have adjusted their ratings and price targets, reflecting their views on the company's market position and financial performance. UnitedHealth Group is a major health insurer with significant market capitalization and revenue growth, but its debt-to-equity ratio is higher than the industry average.
January 16, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
UnitedHealth Group has a diverse set of analyst ratings, with a slight decrease in the average price target to $573. The company shows strong financial health with high ROE and ROA, but has a higher debt-to-equity ratio than its peers.
The mixed analyst ratings and slight decrease in the average price target suggest a neutral short-term impact on UNH's stock price. The company's strong financial performance could counterbalance concerns over its debt levels, leading to a neutral score. The relevance is 100 as UNH is the primary focus of the article, and the importance is set at 75 due to the significance of analyst ratings on investor sentiment. The confidence level is 90, reflecting the clear data provided on analyst ratings and price targets.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100